Blocking brain’s ‘internal marijuana’ may trigger early Alzheimer’s deficits, study shows

A new study has implicated the blocking of endocannabinoids — signaling substances that are the brain’s internal versions of the psychoactive chemicals in marijuana and hashish — in the early pathology of Alzheimer’s disease.